MedApp S.A. (WSE:MDA)
Poland · Delayed Price · Currency is PLN 0.2100
0.00 (0.00%)
At close: Jun 3, 2026
MedApp Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5.5 | 3.84 | 7.2 | 5.74 | 6.73 | 12.71 | |
Revenue Growth (YoY) | -25.44% | -46.69% | 25.55% | -14.82% | -47.02% | 110.92% |
Cost of Revenue | 3.3 | 2.56 | 1.84 | 1.6 | 1.5 | 1.85 |
Gross Profit | 2.2 | 1.28 | 5.36 | 4.14 | 5.23 | 10.86 |
Selling, General & Admin | 2.21 | 2.37 | 2.98 | 3.71 | 5.47 | 5.5 |
Other Operating Expenses | 0.38 | 0.27 | -0.09 | 1.12 | -1.51 | 0.41 |
Operating Expenses | 2.6 | 2.64 | 2.89 | 4.83 | 3.96 | 5.91 |
Operating Income | -0.4 | -1.37 | 2.47 | -0.69 | 1.28 | 4.96 |
Interest Expense | -0.65 | -0.64 | -0.14 | -0.22 | -0 | - |
Interest & Investment Income | - | - | 0.01 | - | - | 0.01 |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0.01 |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | -0 | - | -0.02 | - |
EBT Excluding Unusual Items | -1.04 | -2 | 2.34 | -0.91 | 1.26 | 4.95 |
Impairment of Goodwill | - | - | - | -0.37 | - | - |
Gain (Loss) on Sale of Investments | - | - | - | -1.55 | -0.06 | -0.53 |
Pretax Income | -1.04 | -2 | 2.34 | -2.83 | 1.2 | 4.42 |
Income Tax Expense | 0.03 | 0.03 | 0.23 | 0.3 | 0.59 | 0.3 |
Earnings From Continuing Operations | -1.07 | -2.02 | 2.11 | -3.13 | 0.61 | 4.12 |
Minority Interest in Earnings | -0.12 | -0.13 | -0.07 | -0.02 | - | - |
Net Income | -1.18 | -2.15 | 2.04 | -3.15 | 0.61 | 4.12 |
Net Income to Common | -1.18 | -2.15 | 2.04 | -3.15 | 0.61 | 4.12 |
Net Income Growth | - | - | - | - | -85.23% | 115.28% |
Shares Outstanding (Basic) | - | - | 250 | 250 | 250 | 250 |
Shares Outstanding (Diluted) | - | - | 250 | 250 | 250 | 250 |
Shares Change (YoY) | - | - | - | - | 0.00% | 0.04% |
EPS (Basic) | - | - | 0.01 | -0.01 | 0.00 | 0.02 |
EPS (Diluted) | - | - | 0.01 | -0.01 | 0.00 | 0.02 |
EPS Growth | - | - | - | - | -85.44% | 115.21% |
Free Cash Flow | 0.62 | 0.49 | 0.69 | -1.33 | -0.8 | -0.68 |
Free Cash Flow Per Share | - | - | 0.00 | -0.01 | -0.00 | -0.00 |
Gross Margin | 39.96% | 33.32% | 74.50% | 72.12% | 77.74% | 85.46% |
Operating Margin | -7.25% | -35.57% | 34.32% | -12.03% | 18.97% | 38.99% |
Profit Margin | -21.52% | -56.05% | 28.28% | -54.94% | 9.04% | 32.44% |
Free Cash Flow Margin | 11.33% | 12.77% | 9.51% | -23.12% | -11.81% | -5.33% |
EBITDA | 0.99 | 0.94 | 5.89 | 4.1 | 3.08 | 6.9 |
EBITDA Margin | 17.96% | 24.49% | 81.83% | 71.51% | 45.67% | 54.27% |
D&A For EBITDA | 1.39 | 2.31 | 3.42 | 4.79 | 1.8 | 1.94 |
EBIT | -0.4 | -1.37 | 2.47 | -0.69 | 1.28 | 4.96 |
EBIT Margin | -7.25% | -35.57% | 34.32% | -12.03% | 18.97% | 38.99% |
Effective Tax Rate | - | - | 9.81% | - | 49.21% | 6.76% |